• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌转移的基因异质性可能与miR-21在翻译过程中对TIMP-3的调控有关。

Genetic heterogeneity of breast cancer metastasis may be related to miR-21 regulation of TIMP-3 in translation.

作者信息

Li Jianyi, Zhang Yang, Zhang Wenhai, Jia Shi, Tian Rui, Kang Ye, Ma Yan, Li Dan

机构信息

Department of Breast Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.

出版信息

Int J Surg Oncol. 2013;2013:875078. doi: 10.1155/2013/875078. Epub 2013 Jul 10.

DOI:10.1155/2013/875078
PMID:23936642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3723359/
Abstract

PURPOSE

MicroRNAs are noncoding RNA molecules that posttranscriptionally regulated expression of target gene and implicate the progress of cancer proliferation, differentiation, and apoptosis. The aim of this study is to determine whether microRNA-21 (miR-21), a specific microRNA implicated in multiple aspects of carcinogenesis, promoted breast cancer metastasis by regulating the tissue inhibitor of metalloproteinase 3 (TIMP-3) gene.

METHODS

miR-21 of serum and tissue from 40 patients (30 patients with breast cancer) were detected by real-time quantitative reverse transcriptase polymerase chain reaction (RT-qPCR). TIMP-3 of tissue from the patient was tested by real-time RT-qPCR. Protein expression of TIMP-3 was evaluated by western blotting. Correlation analysis was performed between miR-21 and TIMP-3.

RESULTS

Of the 40 samples from tissue and serum analyzed, the miR-21 expression was significantly higher in high invasion metastasis group (HIMG) that in low invasion metastasis group (LIMG); the latter was higher than that in normal group (NG). Additionally, the TIMP-3 expression was significantly lower in HIMG than in LIMG; the latter was lower than that in NG. There was significantly inverse correlation between miR-21 and TIMP-3 extracted from tissue.

CONCLUSION

Our data suggest that miR-21 could promote metastasis in breast cancer via the regulation of TIMP3 translation, and there was consistency between miR-21 of serum and miR-21 in tissue.

摘要

目的

微小RNA是非编码RNA分子,可在转录后调节靶基因的表达,并与癌症增殖、分化和凋亡进程相关。本研究旨在确定微小RNA-21(miR-21)这种参与致癌作用多个方面的特定微小RNA是否通过调节金属蛋白酶组织抑制剂3(TIMP-3)基因来促进乳腺癌转移。

方法

采用实时定量逆转录聚合酶链反应(RT-qPCR)检测40例患者(30例乳腺癌患者)血清和组织中的miR-21。采用实时RT-qPCR检测患者组织中的TIMP-3。通过蛋白质印迹法评估TIMP-3的蛋白表达。对miR-21和TIMP-3进行相关性分析。

结果

在分析的40份组织和血清样本中,高侵袭转移组(HIMG)的miR-21表达显著高于低侵袭转移组(LIMG);低侵袭转移组高于正常组(NG)。此外,HIMG中TIMP-3的表达显著低于LIMG;LIMG低于NG。从组织中提取的miR-21与TIMP-3之间存在显著负相关。

结论

我们的数据表明,miR-21可通过调节TIMP3的翻译来促进乳腺癌转移,血清中的miR-21与组织中的miR-21具有一致性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826a/3723359/412c5645a910/IJSO2013-875078.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826a/3723359/fe72e4f73bf0/IJSO2013-875078.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826a/3723359/fb7aa45fe0c1/IJSO2013-875078.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826a/3723359/85e7d45a591c/IJSO2013-875078.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826a/3723359/412c5645a910/IJSO2013-875078.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826a/3723359/fe72e4f73bf0/IJSO2013-875078.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826a/3723359/fb7aa45fe0c1/IJSO2013-875078.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826a/3723359/85e7d45a591c/IJSO2013-875078.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826a/3723359/412c5645a910/IJSO2013-875078.004.jpg

相似文献

1
Genetic heterogeneity of breast cancer metastasis may be related to miR-21 regulation of TIMP-3 in translation.乳腺癌转移的基因异质性可能与miR-21在翻译过程中对TIMP-3的调控有关。
Int J Surg Oncol. 2013;2013:875078. doi: 10.1155/2013/875078. Epub 2013 Jul 10.
2
Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.微血管密度差异分布(可能受miR - 374a调控)对乳腺癌预后的影响。
Asian Pac J Cancer Prev. 2013;14(3):1715-20. doi: 10.7314/apjcp.2013.14.3.1715.
3
MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression.微小 RNA-21 通过靶向金属蛋白酶组织抑制剂 3 的表达来部分调节乳腺癌的侵袭。
J Exp Clin Cancer Res. 2010 Mar 27;29(1):29. doi: 10.1186/1756-9966-29-29.
4
TIMP-3 mRNA expression levels positively correlates with levels of miR-21 in in situ BC and negatively in PR positive invasive BC.在原位乳腺癌中,TIMP - 3 mRNA表达水平与miR - 21水平呈正相关,而在孕激素受体(PR)阳性的浸润性乳腺癌中呈负相关。
Pathol Res Pract. 2017 Oct;213(10):1264-1270. doi: 10.1016/j.prp.2017.08.012. Epub 2017 Sep 6.
5
Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers.miR-20a和miR-20b的差异分布可能是乳腺癌转移异质性的基础。
Asian Pac J Cancer Prev. 2012;13(5):1901-6. doi: 10.7314/apjcp.2012.13.5.1901.
6
Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.肿瘤抑制性微小RNA-34a通过靶向致癌蛋白TPD52抑制乳腺癌细胞的迁移和侵袭。
Tumour Biol. 2016 Jun;37(6):7481-91. doi: 10.1007/s13277-015-4623-4. Epub 2015 Dec 17.
7
MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer.微小RNA-124通过靶向Ets-1抑制乳腺癌细胞的增殖和侵袭。
Tumour Biol. 2014 Nov;35(11):10897-904. doi: 10.1007/s13277-014-2402-2. Epub 2014 Aug 2.
8
miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.miR-1290 及其潜在靶标与雌激素受体 α 阳性乳腺癌的特征相关。
Endocr Relat Cancer. 2013 Feb 18;20(1):91-102. doi: 10.1530/ERC-12-0207. Print 2013 Feb.
9
miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.乳腺癌中的微小RNA表达随淋巴结转移及其他临床病理特征而变化。
IUBMB Life. 2014 May;66(5):371-7. doi: 10.1002/iub.1273. Epub 2014 May 20.
10
BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer.骨形态发生蛋白6通过靶向微小RNA-192抑制乳腺癌细胞增殖。
Biochim Biophys Acta. 2013 Dec;1832(12):2379-90. doi: 10.1016/j.bbadis.2013.08.011. Epub 2013 Sep 6.

引用本文的文献

1
MicroRNA-1297 downregulation inhibits breast cancer cell epithelial-mesenchymal transition and proliferation in a FA2H-dependent manner.微小RNA-1297的下调以FA2H依赖的方式抑制乳腺癌细胞的上皮-间质转化和增殖。
Oncol Lett. 2020 Dec;20(6):277. doi: 10.3892/ol.2020.12140. Epub 2020 Sep 23.
2
Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer.乳腺癌中基于微小RNA治疗的潜在微小RNA
Noncoding RNA. 2020 Jul 13;6(3):29. doi: 10.3390/ncrna6030029.
3
Plasma Level Of miR-21 And miR-451 In Primary And Recurrent Breast Cancer Patients.

本文引用的文献

1
Breast cancer statistics, 2011.乳腺癌统计数据,2011 年。
CA Cancer J Clin. 2011 Nov-Dec;61(6):409-18. doi: 10.3322/caac.20134. Epub 2011 Oct 3.
2
MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells.微小 RNA miR-21 调节 B16 黑色素瘤细胞的转移行为。
J Biol Chem. 2011 Nov 11;286(45):39172-8. doi: 10.1074/jbc.M111.285098. Epub 2011 Sep 22.
3
Epithelial-mesenchymal transition in breast cancer progression and metastasis.上皮-间质转化在乳腺癌进展和转移中的作用
原发性和复发性乳腺癌患者中miR-21和miR-451的血浆水平
Breast Cancer (Dove Med Press). 2019 Oct 25;11:293-301. doi: 10.2147/BCTT.S224333. eCollection 2019.
4
TIMP-3 as a therapeutic target for cancer.基质金属蛋白酶组织抑制因子-3作为癌症的治疗靶点。
Ther Adv Med Oncol. 2019 Jul 16;11:1758835919864247. doi: 10.1177/1758835919864247. eCollection 2019.
5
Emerging ways to treat breast cancer: will promises be met?新兴的乳腺癌治疗方法:能否兑现承诺?
Cell Oncol (Dordr). 2018 Dec;41(6):605-621. doi: 10.1007/s13402-018-0409-1. Epub 2018 Sep 27.
6
The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets.微小RNA在乳腺癌转移中的作用:临床前验证及潜在治疗靶点
Cancer Genomics Proteomics. 2018 Jan-Feb;15(1):17-39. doi: 10.21873/cgp.20062.
7
miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development.微小RNA-21可能参与乳腺癌的进展和侵袭,而非乳腺癌发生的起始事件。
Mol Diagn Ther. 2016 Apr;20(2):97-110. doi: 10.1007/s40291-016-0186-3.
8
Enrichment Analysis Identifies Functional MicroRNA-Disease Associations in Humans.富集分析确定人类中功能性微小RNA与疾病的关联。
PLoS One. 2015 Aug 21;10(8):e0136285. doi: 10.1371/journal.pone.0136285. eCollection 2015.
9
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.微小RNA:乳腺癌诊断、预后、治疗预测的新型生物标志物及治疗工具
Theranostics. 2015 Jul 13;5(10):1122-43. doi: 10.7150/thno.11543. eCollection 2015.
10
Small RNAs in metastatic and non-metastatic oral squamous cell carcinoma.转移性和非转移性口腔鳞状细胞癌中的小RNA
BMC Med Genomics. 2015 Jun 24;8:31. doi: 10.1186/s12920-015-0102-4.
Chin J Cancer. 2011 Sep;30(9):603-11. doi: 10.5732/cjc.011.10226.
4
Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53.使用包含 Ki-67 和 p53 的生物标志物组合,可改善早期 ER+ 乳腺癌的预后预测。
Br J Cancer. 2011 Jul 12;105(2):272-80. doi: 10.1038/bjc.2011.228. Epub 2011 Jun 28.
5
Histopathological diagnostics of malignant melanoma in accordance with the recent AJCC classification 2009: Review of the literature and recommendations for general practice.根据 2009 年 AJCC 分类的恶性黑素瘤的组织病理学诊断:文献复习及对全科医学的建议。
J Dtsch Dermatol Ges. 2011 Sep;9(9):690-9. doi: 10.1111/j.1610-0387.2011.07714.x. Epub 2011 Jun 9.
6
MicroRNA profiling in cancer.癌症中的 microRNA 分析。
Clin Sci (Lond). 2011 Aug;121(4):141-58. doi: 10.1042/CS20110005.
7
Factors influencing the outcome of breast cancer patients with 10 or more metastasized axillary lymph nodes.影响 10 个或更多腋窝转移淋巴结的乳腺癌患者结局的因素。
Int J Clin Oncol. 2011 Oct;16(5):473-81. doi: 10.1007/s10147-011-0207-5. Epub 2011 Mar 1.
8
Matrix metalloproteinases and their role in the renal epithelial mesenchymal transition.基质金属蛋白酶及其在肾上皮间质转化中的作用。
Histol Histopathol. 2011 Mar;26(3):307-13. doi: 10.14670/HH-26.307.
9
Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.直接检测早期和晚期乳腺癌患者血清中 microRNA-21 浓度。
Clin Chem. 2011 Jan;57(1):84-91. doi: 10.1373/clinchem.2010.151845. Epub 2010 Oct 29.
10
Gene expression profiling in breast cancer.乳腺癌基因表达谱分析。
Cancer Control. 2010 Jul;17(3):177-82. doi: 10.1177/107327481001700306.